UK vs USA Healthcare Policies

Background Information

President Barack Obama passed the Affordable Care Act in 2010. The legislation’s objective was to ensure that all Americans have access to health insurance and rein down healthcare expenditures and prices. The changes mainly impacted the insurance sector and were phased in starting in 2010, when the legislation was enacted. Advocates of the changes assert that they would reduce costs and enhance access to healthcare, whereas critics claim that the law will raise prices and degrade the standard of healthcare delivery. The legislation has been challenged in court on many occasions. According to a Kaiser Family Foundation survey, 78 percent of the population think the legislation will be challenged in the future (McIntyre et al., 2020). Given the complexity and scale of the healthcare sector, which represents one-sixth of total expenditure in the United States, and the political controversy regarding the legislation, the bill’s changes remain unclear. They will be carefully monitored over the next few years. On the other hand, the United Kingdom’s policies are not dissimilar to those of the United States, as they have rated the nation highly in world-class healthcare service. Apart from that, the United Kingdom has outperformed the United States in terms of economic justice, resulting from the country’s tax-based system policy. The following paragraphs will compare specific health care systems of the two nations in detail.

Implementation Challenges

There are several implementation issues in the U.S and U.K. For instance, the United States has the challenge of reacting to urgent worldwide health problems that have domestic ramifications since people, food, goods, illnesses, and environmental dangers travel quicker than before. Global markets increasingly dictate food safety and the availability, quality, and cost of medicines, blood products, and medical equipment. Also, the United States confronts challenges in resolving state and local concerns resulting from developing federal laws and programs targeting particular illnesses, services, demographics, providers, and places. These category programs do not promote effective federal-state collaboration or engage local government and community-based groups in formulating policy that affects them. However, the administration is not accountable, besides the devolved authority and governance in the United Kingdom. For example, local governments are mainly responsible for environmental preservation, yet most of the public is focused on national politics, leaving local governments with little responsibility (Sharpe, 2019). This leads to the poor execution of the policies that have been established. Institutional considerations have played a significant role in delaying strategy implementation and raising criticism of anti-capitalist measures.

Key stakeholders

Individuals or organizations having an interest in or who are affected by performance measures are considered stakeholders. As such, caregivers, patients, doctors, measure creators, and healthcare of facilities representatives are all examples of stakeholders.

Policy Dynamics

The two medical healthcare programs of America and the United Kingdom are comparable in their aims, objectives, and target groups. Both policies were developed to make healthcare more accessible and cheap to their people. The U.S. ACA program offers affordable health insurance to the country’s middle- and upper-income people (Chattopadhyay, 2018). Additionally, it assists low-income residents by providing free medical coverage to individuals who earn less than 138 percent of the federal government’s housing standard. This implies that the policy benefits the majority of the U.S. people, indicating that it is on the right track toward achieving its long-term objectives. The United Kingdom’s NHS policy is unquestionable in this instance since it offers all inhabitants and citizens free accessibility to medical health care services at any moment they require it (Swampillai et al., 2020). Both legislations were developed with nationals, non-citizen residents, and tourists as their primary target groups for receiving medical health care services as defined by the two regulations.

Key Planning Issues

Medicare Advantage Innovation in the United States and social obstacles in the United Kingdom are two policy objectives for health insurance providers. They seek to enhance efficiency in the delivery of healthcare. For example, Medicare Advantage specializes in new, creative initiatives that improve care delivery, reduce costs, and result in healthier patients (Chattopadhyay, 2018). Additionally, the socioeconomic circumstances in which individuals reside in the United Kingdom significantly affect their health policy. By tackling these essential needs, which include insufficient access to healthy food, a shortage of housing, problematic and inefficient modes of transportation, and constrained career options for good education and decent jobs, the United Kingdom’s government can improve individual and community health.

Current Events

The Affordable Care Act of the U. S. has succeeded in accomplishing most of the goals set out during its development. The program has benefited many residents of the U.S by providing cheap medical health care coverage. Additionally, it included individuals with less than 138 percent of the federal government’s property value, easing the burden on the region’s low-income inhabitants (McIntyre et al., 2020). In the United States, most of these data may be ascribed to the Affordable Care Act legislation.

However, execution of the program remains a challenge since ten million over fifty million U.S people remain uninsured owing to exorbitant rates. As a result, while the program did not completely solve the issue it was designed to solve, it did result in substantial changes in the target demographic in the United States. On the other hand, the United Kingdom’s National Health Service program has succeeded in achieving its stated objective since every person is guaranteed comprehensive and accessible medical treatment (Swampillai et al., 2020). The policy’s sole remaining objective is to raise quality and provide more resources to contend with the private companies in the nation.